Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?

被引:8
作者
Maymon, R [1 ]
Weinraub, Z [1 ]
Herman, A [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, IL-70300 Zerifin, Israel
关键词
euploid fetuses; fetal abnormalities; increased nuchal translucency; pregnancy outcome;
D O I
10.1515/JPM.2005.036
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aims: The number of fetuses with an abnormal increased first trimester nuchal translucency (NT), but confirmed normal karyotype and anatomy is relatively small and therefore a challenge for prenatal counseling. Universal guidelines are still needed for a systematic work-up, how to decide on the rewarding cut-off for this policy as well as how to counsel patients with an increased NT but with euploid fetuses. The current review aims to address some of these issues. Results: Eleven studies reporting on the pregnancy outcome of 2,128 euploid fetuses with increased NT (>= 3 mm or >= 95 centile) were retrieved by our previously reported literature search. 2.2-10.6% of the fetuses has miscarried and 0.5-15.8% ended in perinatal death. There was an overall rate of 0.5-13% neurodevelopmental problems, and 2-8% of the malformations were undiagnosed before birth, the most common being cardiac anomalies. Nevertheless, 70-90% fetuses had normal outcomes. Conclusion: For those euploid fetuses with increased NT > 2 MoM or >= 1.5 mm delta NT we recommend a detailed two-step anomaly scan including midgestation fetal echocardiography. Maternal age as well as data on relevant family history and persistence of nuchal edema provides additional relevant information for counseling and planning pregnancy management.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 60 条
[1]  
Achiron R, 2000, AM J MED GENET, V92, P159, DOI 10.1002/(SICI)1096-8628(20000529)92:3<159::AID-AJMG1>3.0.CO
[2]  
2-2
[3]  
BenAmi M, 1997, ULTRASOUND OBST GYN, V10, P297
[4]   Outcome of fetuses with enlarged nuchal translucency and normal karyotype [J].
Bilardo, CM ;
Pajkrt, E ;
de Graaf, I ;
Mol, BW ;
Bleker, OP .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (06) :401-406
[5]   Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation [J].
Brady, AF ;
Pandya, PP ;
Yuksel, B ;
Greenough, A ;
Patton, MA ;
Nicolaides, KH .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) :222-224
[6]   Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography [J].
Braithwaite, JM ;
Armstrong, MA ;
Economides, DL .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (01) :82-85
[7]   CONGENITAL ANEMIA AFTER TRANSPLACENTAL B19 PARVOVIRUS INFECTION [J].
BROWN, KE ;
GREEN, SW ;
DEMAYOLO, JA ;
BELLANTI, JA ;
SMITH, SD ;
SMITH, TJ ;
YOUNG, NS .
LANCET, 1994, 343 (8902) :895-896
[8]   Increased fetal nuchal translucency: possible association with esophageal atresia [J].
Brown, RN ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 15 (06) :531-532
[9]   Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening [J].
Cheng, CC ;
Bahado-Singh, RO ;
Chen, SC ;
Tsai, MS .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 84 (01) :5-9
[10]  
CUNNINGHAM FG, 1997, WILLIAMS OBSTET